Recent Blog Posts

View Post: Combination of valsartan, amlodipine and hydrochlorothiazide ...
26 Oct 2009
According to PharmaLive, the European Commission has granted marketing authorisation to Novartis for Exforge HCT®, a once-daily combination tablet containing valsartan, amlodipine, and hydrochlorothiazide (HCT) for hypertension. ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: Effects of valsartan on morbidity and mortality in uncontrolled ...
14 Oct 2009 by Sawada, T., Yamada, H., Dahlof, B., Matsubara,...  
A total of 3031 Japanese patients (43% female, mean 66 years) with uncontrolled hypertension were randomized to either valsartan add-on or non-ARB treatment. Median follow-up period was 3.27 years. In both groups, blood pressure at ...
View Blog: European Heart Journal - recent issues - http://eurheartj.oxfordjournals.org/

---

View Post: FDA approves aliskiren/valsartan combo for hypertension
22 Sep 2009
Silver Spring, MD - The US Food and Drug Administration has approved a single-pill combination of the direct renin inhibitor aliskiren and the angiotensin-receptor blocker valsartan (Valturna, Novartis) for the treatment of hypertension ...
View Blog: theHeart.org - http://www.theheart.org/

---

View Post: Pharmacy Europe - Novartis receives approval in the EU for Exforge HCT
29 Oct 2009
... medications: the angiotensin receptor blocker valsartan (Diovan), the calcium channel blocker amlodipine, and the diuretic hydrochlorothiazide (HCT). All three have been used extensively for many years in patients with hypertension. ...
View Blog: Pharmacy Europe - http://www.pharmacyeurope.net/rss.asp

---

View Post: Novartis receives approval in the European Union for Exforge HCT ...
23 Oct 2009 by insciences  
Twenty-four hour ambulatory BP Control of therapy with amlodipine/valsartan/HCTZ triple combination compared to dual therapy in patients with moderate to severe hypertension. Presented at the 19th Scientific Meeting of the European ...
View Blog: Articles - http://insciences.org/articles.php

---

View Post: Valsartan reduces morbidity and mortality in Japanese patients ...
1 Sep 2009
The study showed that valsartan has the additional benefits of cardiovascular event prevention for hypertensive patients in East Asia with metabolic syndrome or high-risks.” * The KYOTO HEART study is registered with ClinicalTrials.gov, ...
View Blog: AlphaGalileo RSS Channel - http://www.alphagalileo.org/

---

View Post: the KYOTO HEART Study: Valsartan reduces morbidity and mortality ...
2 Sep 2009 by AntonioCaperna  
The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved ...
View Blog: SALUTE DOMANI ∞ IL PORTALE DEL BENESSERE - http://www.salutedomani.com/il_weblog_di_antonio/

---